On September 1, 2009
Genzyme’s Triple Screwup: Factory Problem Ends Its Monopoly and Puts NDA on Hold
Is there a drug company on the planet more screwed up than Genzyme right now? (Possibly, but it’s a tight contest.) Here’s what’s happening at the maker of Cerezyme, the only treatment for Gaucher disease, which gives Genzyme a $1.24 billion monopoly on the drug.
0 Comments